Tiotropium bromide
From Proteopedia
(Difference between revisions)
| Line 5: | Line 5: | ||
<scene name='10/1013887/Cv/3'>M3 muscarinic acetylcholine receptor bound to the antagonist tiotropium</scene> ([[4u14]]). | <scene name='10/1013887/Cv/3'>M3 muscarinic acetylcholine receptor bound to the antagonist tiotropium</scene> ([[4u14]]). | ||
| + | |||
| + | <scene name='10/1013887/Binding_site/1'>Tiotropium binding site</scene>. | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 07:29, 12 December 2023
| |||||||||||
References
- ↑ 1.0 1.1 "Tiotropium Bromide Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Archived from the original on 14 October 2018. Retrieved 31 January 2019.
- ↑ British national formulary : BNF 76 (76th ed.). Pharmaceutical Press. 2018. pp. 247–248. ISBN 9780857113382.
- ↑ Kato M, Komamura K, Kitakaze M. Tiotropium, a novel muscarinic M3 receptor antagonist, improved symptoms of chronic obstructive pulmonary disease complicated by chronic heart failure. Circ J. 2006 Dec;70(12):1658-60. PMID:17127817 doi:10.1253/circj.70.1658
